speb/financial-data huggingface dataset:
DuPont ROE decomposition for MCG.L (annual period ending 2021-12-31)
ROE: -5.223931160647742%
Net margin: -3.552504262083583%
Asset turnover: 0.5044042113091779
Equity multiplier (leverage): 2.915305915034894
EBIT margin: 1.824632539280284%
Interest burden factor: -2.143939393939394
ROE archetype: Low Return
DuPont ROE decomposition for MCG.L (annual period ending 2022-12-31)
ROE: -15.264749561587237%
Net margin: -8.235084594835262%
Asset turnover: 0.6247217574300634
Equity multiplier (leverage): 2.967119154143296
EBIT margin: 5.146927871772039%
Interest burden factor: -1.5591695501730105
ROE archetype: Low Return
DuPont ROE decomposition for MCG.L (annual period ending 2023-12-31)
ROE: -15.66264751666934%
Net margin: -5.845948776540037%
Asset turnover: 0.7841452117764188
Equity multiplier (leverage): 3.416753703571851
EBIT margin: 3.814783077850773%
Interest burden factor: -0.9991680532445923
ROE archetype: Low Return
DuPont ROE decomposition for MCG.L (annual period ending 2024-12-31)
ROE: -124.16496800846642%
Net margin: -23.262220138319073%
Asset turnover: 0.9266299962447335
Equity multiplier (leverage): 5.760253081097027
EBIT margin: 4.342984409799555%
Interest burden factor: -4.111336032388664
ROE archetype: Low Return
DuPont ROE decomposition for MCGA (annual period ending 2025-12-31)
Equity multiplier (leverage): 1.0426135736637137
ROE archetype: Standard Business
DuPont ROE decomposition for MCP.DE (annual period ending 2023-03-31)
ROE: 34.354274134119386%
Net margin: 26.517117565501795%
Asset turnover: 0.5154884149954491
Equity multiplier (leverage): 2.513249201670351
EBIT margin: 36.87771813193975%
Interest burden factor: 0.9349935732647815
Tax burden factor: 0.769048355500567
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MCP.DE (annual period ending 2024-03-31)
ROE: 28.955160423341482%
Net margin: 24.97773236927591%
Asset turnover: 0.47354660629274115
Equity multiplier (leverage): 2.4479933795951836
EBIT margin: 33.51540396101855%
Interest burden factor: 0.9246492359401258
Tax burden factor: 0.8059934908491483
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MCP.DE (annual period ending 2025-03-31)
ROE: -0.007280086778634402%
Net margin: -0.011359505634314794%
Asset turnover: 0.28172223324522044
Equity multiplier (leverage): 2.2748669564141206
EBIT margin: 8.53098873137041%
Interest burden factor: 0.10359520639147803
Tax burden factor: -0.012853470437017995
ROE archetype: Low Return
DuPont ROE decomposition for MCP.DE (annual period ending 2026-03-31)
ROE: 3.404708860384732%
Net margin: 4.880015276569562%
Asset turnover: 0.316903515584289
Equity multiplier (leverage): 2.201566166075777
EBIT margin: 11.241009102289363%
Interest burden factor: 0.5162325405813515
Tax burden factor: 0.8409506398537477
ROE archetype: Low Return
DuPont ROE decomposition for MCR (annual period ending 2022-11-30)
ROE: -12.927546119118308%
Asset turnover: -0.09261774566534996
Equity multiplier (leverage): 1.3769007730924459
ROE archetype: Low Return
DuPont ROE decomposition for MCR (annual period ending 2023-11-30)
ROE: 5.640335100001149%
Net margin: 96.9558377949024%
Asset turnover: 0.0424544833998895
Equity multiplier (leverage): 1.3702738906723781
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MCR (annual period ending 2024-11-30)
ROE: 10.505098256105281%
Net margin: 98.3410161588465%
Asset turnover: 0.07907479906043098
Equity multiplier (leverage): 1.3509128422588321
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MCR (annual period ending 2025-11-30)
ROE: 6.183261720942739%
Net margin: 97.13968268072057%
Asset turnover: 0.04739810223952469
Equity multiplier (leverage): 1.3429504699824728
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MCRI (quarterly period ending 2025-03-31)
ROE: 3.7084955240042192%
Net margin: 15.841268322248272%
Asset turnover: 0.1760938987706541
Equity multiplier (leverage): 1.3294239547453024
EBIT margin: 20.190758728487808%
Interest burden factor: 1.0124812386444426
Tax burden factor: 0.7749083248810174
ROE archetype: Low Return
DuPont ROE decomposition for MCRI (quarterly period ending 2025-06-30)
ROE: 5.02529579991106%
Net margin: 19.726251515549908%
Asset turnover: 0.1931260367649548
Equity multiplier (leverage): 1.3190954914120805
EBIT margin: 25.489723476050656%
Interest burden factor: 1.0112324135362045
Tax burden factor: 0.76529426766031
ROE archetype: Standard Business
DuPont ROE decomposition for MCRI (quarterly period ending 2025-09-30)
ROE: 5.753523750868923%
Net margin: 22.109877182909237%
Asset turnover: 0.19957657021877206
Equity multiplier (leverage): 1.3038812051132311
EBIT margin: 26.729172210007423%
Interest burden factor: 1.0150630026458491
Tax burden factor: 0.8149065758232683
ROE archetype: Standard Business
DuPont ROE decomposition for MCRI (quarterly period ending 2025-12-31)
ROE: 4.186685595312605%
Net margin: 16.388220252423164%
Asset turnover: 0.19468750890850092
Equity multiplier (leverage): 1.3122013127186267
EBIT margin: 20.78884023913773%
Interest burden factor: 1.022470365916509
Tax burden factor: 0.7709936489801404
ROE archetype: Low Return
DuPont ROE decomposition for MCRI (quarterly period ending 2026-03-31)
ROE: 5.074302150123354%
Net margin: 20.206517759062613%
Asset turnover: 0.18991351320528252
Equity multiplier (leverage): 1.3222968978013259
EBIT margin: 25.59209080922739%
Interest burden factor: 1.0171121158358611
Tax burden factor: 0.7762772901192888
ROE archetype: Standard Business
DuPont ROE decomposition for MCX.NS (annual period ending 2023-03-31)
ROE: 10.07030352193605%
Net margin: 33.27525743259845%
Asset turnover: 0.14810685633942602
Equity multiplier (leverage): 2.043365105117285
EBIT margin: 29.89568674752619%
Interest burden factor: 1.4238643156007171
Tax burden factor: 0.781707509051792
ROE archetype: Standard Business
DuPont ROE decomposition for MCX.NS (annual period ending 2024-03-31)
ROE: 5.769497297722405%
Net margin: 14.24238269870103%
Asset turnover: 0.18013176074022985
Equity multiplier (leverage): 2.2488735101998
EBIT margin: 5.626006786167187%
Interest burden factor: 3.106305208650624
Tax burden factor: 0.8149637183761521
ROE archetype: Standard Business
DuPont ROE decomposition for MCX.NS (annual period ending 2025-03-31)
ROE: 33.958176158841994%
Net margin: 50.33343519134327%
Asset turnover: 0.28450057827053526
Equity multiplier (leverage): 2.3713989978648584
EBIT margin: 54.06503334351913%
Interest burden factor: 1.1626437928053728
Tax burden factor: 0.8007434944237918
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MCX.NS (annual period ending 2026-03-31)
ROE: 54.055098169744134%
Net margin: 57.843179843614244%
Asset turnover: 0.37517010207098517
Equity multiplier (leverage): 2.4908999236436906
EBIT margin: 68.13814074717635%
Interest burden factor: 1.0776454537340459
Tax burden factor: 0.787745588139594
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MD (annual period ending 2022-12-31)
ROE: 7.439728497855618%
Net margin: 3.363807991902723%
Asset turnover: 0.8399130792921465
Equity multiplier (leverage): 2.633246675758609
EBIT margin: 10.141879827851733%
Interest burden factor: 0.40685
Tax burden factor: 0.8152267420425218
ROE archetype: Standard Business
DuPont ROE decomposition for MD (annual period ending 2023-12-31)
ROE: -6.940683968970979%
Net margin: -3.028516424016364%
Asset turnover: 0.8733679138524294
Equity multiplier (leverage): 2.624068115400016
EBIT margin: 7.91380900814182%
Interest burden factor: -0.30635658718293085
ROE archetype: Low Return
DuPont ROE decomposition for MD (annual period ending 2024-12-31)
ROE: -12.276215784520312%
Net margin: -4.92165854661812%
Asset turnover: 0.920715561542455
Equity multiplier (leverage): 2.70911568098865
EBIT margin: 9.125106375368308%
Interest burden factor: -0.5517228238086683
ROE archetype: Low Return
DuPont ROE decomposition for MD (annual period ending 2025-12-31)
ROE: 20.283150763555376%
Net margin: 8.641643097234944%
Asset turnover: 0.8700507978822547
Equity multiplier (leverage): 2.6977051641165763
EBIT margin: 12.074359053404944%
Interest burden factor: 0.9365904320920874
Tax burden factor: 0.7641568714423006
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MDA.TO (quarterly period ending 2025-03-31)
ROE: 2.707373271889401%
Net margin: 9.373219373219372%
Asset turnover: 0.1231233338010383
Equity multiplier (leverage): 2.345951283739302
EBIT margin: 10.056980056980057%
Interest burden factor: 1.28328611898017
Tax burden factor: 0.7262693156732892
ROE archetype: Low Return
DuPont ROE decomposition for MDA.TO (quarterly period ending 2025-06-30)
ROE: 2.2235732724160235%
Net margin: 7.286364854004823%
Asset turnover: 0.1268027265178937
Equity multiplier (leverage): 2.4066444800976874
EBIT margin: 11.679614251272437%
Interest burden factor: 0.8211009174311926
Tax burden factor: 0.7597765363128491
ROE archetype: Low Return
DuPont ROE decomposition for MDA.TO (quarterly period ending 2025-09-30)
ROE: 1.8552877755139536%
Net margin: 5.954123962908736%
Asset turnover: 0.12263617112392682
Equity multiplier (leverage): 2.5408254332270124
EBIT margin: 8.077110785749147%
Interest burden factor: 1.1722054380664653
Tax burden factor: 0.6288659793814433
ROE archetype: Low Return
DuPont ROE decomposition for MDA.TO (quarterly period ending 2025-12-31)
ROE: 1.8010085323858966%
Net margin: 4.808655580044079%
Asset turnover: 0.14708564350883355
Equity multiplier (leverage): 2.546371785711297
EBIT margin: 9.176517731917452%
Interest burden factor: 0.7096069868995633
Tax burden factor: 0.7384615384615385
ROE archetype: Low Return
DuPont ROE decomposition for MDA.TO (quarterly period ending 2026-03-31)
ROE: 1.8376640929309165%
Net margin: 6.377935789700497%
Asset turnover: 0.12888989300580203
Equity multiplier (leverage): 2.2354611346415676
EBIT margin: 8.640379228614522%
Interest burden factor: 1.027431421446384
Tax burden factor: 0.7184466019417476
ROE archetype: Low Return
DuPont ROE decomposition for MDCX (annual period ending 2022-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MDCX (annual period ending 2023-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MDCX (annual period ending 2024-12-31)
ROE: -525.4411994671882%
Asset turnover: 0
Equity multiplier (leverage): 1.7757101017580152
ROE archetype: Low Return
DuPont ROE decomposition for MDCX (annual period ending 2025-12-31)
ROE: -2234.8075277071516%
Asset turnover: 0
Equity multiplier (leverage): 4.9521376790462845
ROE archetype: Low Return
DuPont ROE decomposition for MDGL (annual period ending 2022-12-31)
ROE: -149.6283987456241%
Asset turnover: 0
Equity multiplier (leverage): 1.8368399454883504
ROE archetype: Low Return
DuPont ROE decomposition for MDGL (annual period ending 2023-12-31)
ROE: -123.9808734375052%
Asset turnover: 0
Equity multiplier (leverage): 1.6643145596145488
ROE archetype: Low Return
DuPont ROE decomposition for MDGL (annual period ending 2024-12-31)
ROE: -80.34587778387122%
Net margin: -258.63778430381996%
Asset turnover: 0.21408799888756438
Equity multiplier (leverage): 1.451039737314998
EBIT margin: -276.39299850665896%
ROE archetype: Low Return
DuPont ROE decomposition for MDGL (annual period ending 2025-12-31)
ROE: -42.48617612035323%
Net margin: -30.079622037910987%
Asset turnover: 0.8327291779257949
Equity multiplier (leverage): 1.6961782425692962
EBIT margin: -31.312193304904095%
ROE archetype: Low Return
DuPont ROE decomposition for MDO.DE (quarterly period ending 2025-03-31)
Net margin: 31.385390428211586%
Asset turnover: 0.10571819134016226
EBIT margin: 44.56759026028547%
Interest burden factor: 0.8779201205727204
Tax burden factor: 0.8021459227467811
ROE archetype: Standard Business
DuPont ROE decomposition for MDO.DE (quarterly period ending 2025-06-30)
Net margin: 32.924156071898295%
Asset turnover: 0.11810085948016982
EBIT margin: 47.65453748355984%
Interest burden factor: 0.8773382398037411
Tax burden factor: 0.7874868926948619
ROE archetype: Standard Business
DuPont ROE decomposition for MDO.DE (quarterly period ending 2025-09-30)
Net margin: 32.18878055673308%
Asset turnover: 0.11779000191406673
EBIT margin: 46.89840327822524%
Interest burden factor: 0.8885206387466105
Tax burden factor: 0.7724652424550695
ROE archetype: Standard Business
DuPont ROE decomposition for MDO.DE (quarterly period ending 2025-12-31)
Net margin: 30.878995433789953%
Asset turnover: 0.11668040258734796
EBIT margin: 45.04851598173516%
Interest burden factor: 0.8732974342730441
Tax burden factor: 0.7849111352919841
ROE archetype: Standard Business
DuPont ROE decomposition for MDO.DE (quarterly period ending 2026-03-31)
Net margin: 30.428111094061684%
Asset turnover: 0.10902368843683083
EBIT margin: 44.25349087003222%
Interest burden factor: 0.8814147018030514
Tax burden factor: 0.7800944138473643
ROE archetype: Standard Business
DuPont ROE decomposition for MDP.TO (quarterly period ending 2024-12-31)
ROE: 2.2144346092263083%
Net margin: 2.4439850626833826%
Asset turnover: 0.2054556165997616
Equity multiplier (leverage): 4.410078245370231
EBIT margin: 12.606695118698319%
Interest burden factor: 0.23274266067177993
Tax burden factor: 0.8329545454545455
ROE archetype: Low Return
DuPont ROE decomposition for MDP.TO (quarterly period ending 2025-03-31)
ROE: -1.2974520200835247%
Net margin: -2.2339823866849797%
Asset turnover: 0.15577566894051906
Equity multiplier (leverage): 3.7283093238233773
EBIT margin: -1.1715278338854325%
ROE archetype: Low Return
DuPont ROE decomposition for MDP.TO (quarterly period ending 2025-06-30)
ROE: 1.0027577605076679%
Net margin: 2.096282754418038%
Asset turnover: 0.15460663033427285
Equity multiplier (leverage): 3.0939839426666302
EBIT margin: 3.4531789559211865%
Interest burden factor: 0.7235294117647058
Tax burden factor: 0.8390243902439024
ROE archetype: Low Return
DuPont ROE decomposition for MDP.TO (quarterly period ending 2025-09-30)
ROE: -0.5934877254072364%
Net margin: -1.2731902510003639%
Asset turnover: 0.16198159340152568
Equity multiplier (leverage): 2.8777480609880666
EBIT margin: 6.681217412392384%
Interest burden factor: -0.19782214156079855
ROE archetype: Low Return
DuPont ROE decomposition for MDP.TO (quarterly period ending 2025-12-31)
ROE: 0.15403160764603482%
Net margin: 0.31590586005370397%
Asset turnover: 0.16755726966793416
Equity multiplier (leverage): 2.909972542342244
EBIT margin: 6.614278944874427%
Interest burden factor: 0.26626865671641786
Tax burden factor: 0.17937219730941703
ROE archetype: Low Return
DuPont ROE decomposition for MDP.TO (quarterly period ending 2026-03-31)
ROE: -5.246990845917725%
Net margin: -10.851046568229759%
Asset turnover: 0.16190273891390222
Equity multiplier (leverage): 2.9866510453642254
EBIT margin: 6.721564173292228%
Interest burden factor: -1.8153289076644537
ROE archetype: Low Return
DuPont ROE decomposition for MDT (annual period ending 2022-04-30)
ROE: 9.601304958082018%
Net margin: 15.975509688821562%
Asset turnover: 0.348270518020246
Equity multiplier (leverage): 1.725674291567088
EBIT margin: 18.64545856214101%
Interest burden factor: 0.9338185511171292
Tax burden factor: 0.9175276418343303
ROE archetype: Standard Business
DuPont ROE decomposition for MDT (annual period ending 2023-04-30)
ROE: 7.40747075199902%
Net margin: 12.117718640919717%
Asset turnover: 0.35067166662795357
Equity multiplier (leverage): 1.7432047614038382
EBIT margin: 18.669740929323982%
Interest burden factor: 0.9200686106346483
Tax burden factor: 0.7054436987322893
ROE archetype: Standard Business
DuPont ROE decomposition for MDT (annual period ending 2024-04-30)
ROE: 7.178806917656802%
Net margin: 11.447905079718204%
Asset turnover: 0.35384441173140074
Equity multiplier (leverage): 1.7722048128060435
EBIT margin: 17.055988134964775%
Interest burden factor: 0.876268115942029
Tax burden factor: 0.7659706429605126
ROE archetype: Standard Business
DuPont ROE decomposition for MDT (annual period ending 2025-04-30)
ROE: 9.776455813753365%
Net margin: 13.987536154098459%
Asset turnover: 0.37932781207752003
Equity multiplier (leverage): 1.8425765241180498
EBIT margin: 19.500849807675106%
Interest burden factor: 0.8605504587155962
Tax burden factor: 0.8335110163468372
ROE archetype: Standard Business
DuPont ROE decomposition for MDT (annual period ending 2026-04-30)
ROE: 9.949473794439502%
Net margin: 13.301616983830161%
Asset turnover: 0.39823821176901625
Equity multiplier (leverage): 1.8782471782367065
EBIT margin: 18.776812231877678%
Interest burden factor: 0.8986526069127124
Tax burden factor: 0.7882985658409387
ROE archetype: Standard Business
DuPont ROE decomposition for MDTBS.PA (annual period ending 2022-12-31)
Net margin: -85.39501478664977%
Asset turnover: 0.6810922798031824
EBIT margin: -97.9087452471483%
ROE archetype: Standard Business
DuPont ROE decomposition for MDTBS.PA (annual period ending 2023-12-31)
Net margin: -103.4014217583011%
Asset turnover: 0.6422850256545839
EBIT margin: -102.9829928912085%
ROE archetype: Standard Business
DuPont ROE decomposition for MDTBS.PA (annual period ending 2024-12-31)
Net margin: -109.98779850095868%
Asset turnover: 0.7319624896336148
EBIT margin: -97.45511591424089%
ROE archetype: Standard Business
DuPont ROE decomposition for MDTBS.PA (annual period ending 2025-12-31)
Net margin: -145.84956547797424%
Asset turnover: 0.8131746194064111
EBIT margin: -68.23494156427928%
ROE archetype: Standard Business
DuPont ROE decomposition for MEDICAMEQ.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.3362279936345263
ROE archetype: Standard Business
DuPont ROE decomposition for MEDICAMEQ.NS (quarterly period ending 2024-12-31)
Net margin: 6.472879035580897%
EBIT margin: 9.958974086331636%
Interest burden factor: 0.8623796071801944
Tax burden factor: 0.7536755223110653
ROE archetype: Standard Business
DuPont ROE decomposition for MEDICAMEQ.NS (quarterly period ending 2025-03-31)
ROE: 1.1340840072657976%
Net margin: 8.159281934562301%
Asset turnover: 0.09965623480357597
Equity multiplier (leverage): 1.394725725523696
EBIT margin: -7.048279634888849%
Tax burden factor: 0.9702445488495363
ROE archetype: Low Return
DuPont ROE decomposition for MEDICAMEQ.NS (quarterly period ending 2025-06-30)
Net margin: 5.001765602349181%
EBIT margin: 6.537607330037543%
Interest burden factor: 0.7572225578337657
Tax burden factor: 1.01037120465531
ROE archetype: Standard Business
DuPont ROE decomposition for MEDICAMEQ.NS (quarterly period ending 2025-09-30)
ROE: 0.9683000466576256%
Net margin: 5.653617356868166%
Asset turnover: 0.12848972854148422
Equity multiplier (leverage): 1.3329538997242298
EBIT margin: 6.993881678531603%
Interest burden factor: 0.8132464383146408
Tax burden factor: 0.9939990308993999
ROE archetype: Low Return
DuPont ROE decomposition for MEDICAMEQ.NS (quarterly period ending 2025-12-31)
Net margin: 3.484869479945%
EBIT margin: 5.431638189240756%
Interest burden factor: 0.8284862043251305
Tax burden factor: 0.7744090198493534
ROE archetype: Standard Business
DuPont ROE decomposition for MEDICAMEQ.NS (quarterly period ending 2026-03-31)
ROE: 1.6138631827254586%
Net margin: 7.33264519362998%
Asset turnover: 0.16303357846642533
Equity multiplier (leverage): 1.3499851206677556
EBIT margin: 6.113450712818196%
Interest burden factor: 1.3646833531125258
Tax burden factor: 0.8789058639840307
ROE archetype: Low Return
DuPont ROE decomposition for MEL.AX (annual period ending 2021-06-30)
ROE: -17.13056375042498%
Equity multiplier (leverage): 1.0992362047952646
ROE archetype: Low Return
DuPont ROE decomposition for MEL.AX (annual period ending 2022-06-30)
ROE: -68.64059726641894%
Equity multiplier (leverage): 1.4338806569466764
ROE archetype: Low Return
DuPont ROE decomposition for MEL.AX (annual period ending 2023-06-30)
ROE: -14.547440992327495%
Net margin: -321.36513420590285%
Asset turnover: 0.026400630094508687
Equity multiplier (leverage): 1.7146423846686734
EBIT margin: -381.2708580267151%
ROE archetype: Low Return
DuPont ROE decomposition for MEL.AX (annual period ending 2024-06-30)
ROE: -265.93789303624465%
Net margin: -555.7833799746267%
Asset turnover: 0.17481289657613203
Equity multiplier (leverage): 2.737166393048659
EBIT margin: -533.6237673472757%
ROE archetype: Low Return
DuPont ROE decomposition for MELG.OL (annual period ending 2022-12-31)
ROE: 7.734057509264219%
Net margin: 38.57356994713376%
Asset turnover: 0.02484127258489056
Equity multiplier (leverage): 8.07130432376383
Tax burden factor: 0.8033693959838716
ROE archetype: Standard Business
DuPont ROE decomposition for MELG.OL (annual period ending 2023-12-31)
ROE: 9.604682562702674%
Net margin: 39.54019630754849%
Asset turnover: 0.031263708494801146
Equity multiplier (leverage): 7.769690191128033
Tax burden factor: 0.7645649988137873
ROE archetype: Standard Business
DuPont ROE decomposition for MELG.OL (annual period ending 2024-12-31)
ROE: 8.69761104344502%
Net margin: 40.540571956631034%
Asset turnover: 0.029379333847433853
Equity multiplier (leverage): 7.302442841789694
Tax burden factor: 0.7762420640882257
ROE archetype: Standard Business
DuPont ROE decomposition for MELG.OL (annual period ending 2025-12-31)
ROE: 9.072476639893171%
Net margin: 40.14730485401293%
Asset turnover: 0.03188162768535026
Equity multiplier (leverage): 7.088085981443032
Tax burden factor: 0.7878912245391323
ROE archetype: Standard Business
DuPont ROE decomposition for MENE.V (quarterly period ending 2024-09-30)
ROE: 8.111391659506927%
Net margin: 24.45534089506588%
Asset turnover: 0.2958503058987711
Equity multiplier (leverage): 1.1211136186530424
EBIT margin: 24.329582162155642%
Interest burden factor: 1.0051689639415944
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MENE.V (quarterly period ending 2024-12-31)
ROE: -6.1388257891424205%
Net margin: -11.773243987102946%
Asset turnover: 0.4520978424078563
Equity multiplier (leverage): 1.1533383420542784
EBIT margin: -13.28344545476677%
ROE archetype: Low Return
DuPont ROE decomposition for MENE.V (quarterly period ending 2025-03-31)
ROE: -1.1793605221817882%
Net margin: -2.8599136665316305%
Asset turnover: 0.3586126982731599
Equity multiplier (leverage): 1.1499209847780048
EBIT margin: -3.366348479094473%
ROE archetype: Low Return
DuPont ROE decomposition for MENE.V (quarterly period ending 2025-06-30)
ROE: -2.062473345529919%
Net margin: -6.267018789560967%
Asset turnover: 0.2940455208133967
Equity multiplier (leverage): 1.1192130867836583
EBIT margin: -6.9452296574939165%
ROE archetype: Low Return
DuPont ROE decomposition for MENE.V (quarterly period ending 2025-09-30)
ROE: 0.33690419034190494%
Net margin: 0.9985097627474557%
Asset turnover: 0.2986084827327017
Equity multiplier (leverage): 1.1299310848271689
EBIT margin: 0.1504800934785186%
Interest burden factor: 6.635494035561557
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for MENE.V (quarterly period ending 2026-03-31)
ROE: 5.644067580066366%
Net margin: 18.541925249332383%
Asset turnover: 0.264656887974501
Equity multiplier (leverage): 1.150149189822029
EBIT margin: 17.518633452980232%
Interest burden factor: 1.05841162206508
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MER.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 3.7412050249379885
ROE archetype: Standard Business
DuPont ROE decomposition for MER.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.830778708152519
ROE archetype: Standard Business
DuPont ROE decomposition for MER.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.7574221677991293
ROE archetype: Standard Business
DuPont ROE decomposition for MERC.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.1007552507272291
ROE archetype: Standard Business
DuPont ROE decomposition for MERC.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.0919438234238075
ROE archetype: Standard Business
DuPont ROE decomposition for MERC.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.0809056138140112
ROE archetype: Standard Business
DuPont ROE decomposition for MERG.V (quarterly period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MERG.V (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MERG.V (quarterly period ending 2025-06-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MERG.V (quarterly period ending 2025-09-30)
Asset turnover: 0
Interest burden factor: 1.030709169715041
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MERG.V (quarterly period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MERG.V (quarterly period ending 2026-03-31)
ROE: -30.525067620538877%
Asset turnover: 0
Equity multiplier (leverage): 3.9199961255775153
ROE archetype: Low Return
DuPont ROE decomposition for META (annual period ending 2022-12-31)
ROE: 18.454734196145186%
Net margin: 19.895548371051976%
Asset turnover: 0.6278516316959839
Equity multiplier (leverage): 1.477388973296318
EBIT margin: 24.821411726367604%
Interest burden factor: 0.9956813156440022
Tax burden factor: 0.8050244630278636
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for META (annual period ending 2023-12-31)
ROE: 28.03919951520541%
Net margin: 28.982520644616095%
Asset turnover: 0.6495822800048152
Equity multiplier (leverage): 1.4893449177247644
EBIT margin: 34.655527716416366%
Interest burden factor: 1.0144809736690124
Tax burden factor: 0.8243653537994433
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for META (annual period ending 2024-12-31)
ROE: 37.140602432959604%
Net margin: 37.90858414234564%
Asset turnover: 0.6506168957654788
Equity multiplier (leverage): 1.5058650109438514
EBIT margin: 42.1760354040401%
Interest burden factor: 1.0184923609109253
Tax burden factor: 0.8824986202114261
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for META (annual period ending 2025-12-31)
ROE: 30.238071421426426%
Net margin: 30.08369574952977%
Asset turnover: 0.6259891757193474
Equity multiplier (leverage): 1.605669200760228
EBIT margin: 41.437855159579236%
Interest burden factor: 1.0318939430328065
Tax burden factor: 0.7035563003304939
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for METN.SW (annual period ending 2022-12-31)
ROE: 26.4889456553406%
Net margin: 21.254727598960276%
Asset turnover: 0.9212081193515586
Equity multiplier (leverage): 1.3528553761023958
EBIT margin: 4.6460899679692105%
Interest burden factor: 4.817833461064276
Tax burden factor: 0.9495462970647635
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for METN.SW (annual period ending 2023-12-31)
ROE: 5.243348419441133%
Net margin: 5.273137058710571%
Asset turnover: 0.7444371804285056
Equity multiplier (leverage): 1.3357082312174726
EBIT margin: 0.17282677905460722%
Interest burden factor: 36.319298245614036
Tax burden factor: 0.8400798634592471
ROE archetype: Standard Business
DuPont ROE decomposition for METN.SW (annual period ending 2024-12-31)
ROE: 10.109644397324743%
Net margin: 18.646531649142617%
Asset turnover: 0.4134386202735883
Equity multiplier (leverage): 1.3113746207031873
EBIT margin: -8.565380001411333%
Tax burden factor: 0.9170701233796658
ROE archetype: Standard Business
DuPont ROE decomposition for METN.SW (annual period ending 2025-12-31)
ROE: -3.4766360628735935%
Net margin: -7.827601621629954%
Asset turnover: 0.31832909714423213
Equity multiplier (leverage): 1.395256899356196
EBIT margin: -13.520776491503911%
ROE archetype: Low Return
DuPont ROE decomposition for MF.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.9911184210526325
ROE archetype: Standard Business
DuPont ROE decomposition for MF.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.1751676016640857
ROE archetype: Standard Business
DuPont ROE decomposition for MF.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.20141189033132
ROE archetype: Standard Business
DuPont ROE decomposition for MFAI.L (annual period ending 2021-12-31)
ROE: 20.64239235774609%
Asset turnover: 0
Equity multiplier (leverage): 1.024228160044303
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MFAI.L (annual period ending 2022-12-31)
ROE: -4.596987109799659%
Net margin: -2614.285714285714%
Asset turnover: 0.0015866938262907204
Equity multiplier (leverage): 1.1082228598440005
EBIT margin: -5514.285714285715%
ROE archetype: Low Return
DuPont ROE decomposition for MFAI.L (annual period ending 2023-12-31)
ROE: -40.10825120807986%
Asset turnover: 0
Equity multiplier (leverage): 1.2259313321063654
ROE archetype: Low Return
DuPont ROE decomposition for MFAI.L (annual period ending 2024-12-31)
ROE: 37.80748950700934%
Asset turnover: 0
Equity multiplier (leverage): 1.1559219401787806
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MFAI.L (annual period ending 2025-12-31)
ROE: -17.117350522865454%
Asset turnover: 0
Equity multiplier (leverage): 1.057963112625206
ROE archetype: Low Return
DuPont ROE decomposition for MFD.AX (annual period ending 2022-12-31)
ROE: 7.058517239722573%
Net margin: 7.3394107445787045%
Asset turnover: 0.3118762716977737
Equity multiplier (leverage): 3.0836846048611153
EBIT margin: 12.364594456330236%
Interest burden factor: 0.7862587346748212
Tax burden factor: 0.7549459047723575
ROE archetype: Standard Business
DuPont ROE decomposition for MFD.AX (annual period ending 2023-12-31)
ROE: -2.107563464239442%
Net margin: -1.8750852766876676%
Asset turnover: 0.3371209108111639
Equity multiplier (leverage): 3.3340641052011555
EBIT margin: 1.4823213902772676%
Interest burden factor: -1.9675019552966715
ROE archetype: Low Return
DuPont ROE decomposition for MFD.AX (annual period ending 2024-12-31)
ROE: 0.34841785694007216%
Net margin: 0.27495971059969265%
Asset turnover: 0.3444691220410122
Equity multiplier (leverage): 3.678587112182944
EBIT margin: 5.067470188230307%
Interest burden factor: 0.06629235056564026
Tax burden factor: 0.8184920043991175
ROE archetype: Low Return
DuPont ROE decomposition for MFD.AX (annual period ending 2025-12-31)
ROE: -39.233417118909486%
Net margin: -23.38645732651407%
Asset turnover: 0.4101214387693592
Equity multiplier (leverage): 4.090526637913912
EBIT margin: 2.703197107900015%
Interest burden factor: -9.011600745918331
ROE archetype: Low Return
DuPont ROE decomposition for MFML.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.948799642390723
ROE archetype: Standard Business
DuPont ROE decomposition for MFML.NS (quarterly period ending 2024-12-31)
Net margin: -2.729923950294443%
EBIT margin: -6.168759863733637%
ROE archetype: Standard Business
DuPont ROE decomposition for MFML.NS (quarterly period ending 2025-03-31)
ROE: 7.3881577737219555%
Net margin: 27.426642135012614%
Asset turnover: 0.13669934389708124
Equity multiplier (leverage): 1.9705937054833293
EBIT margin: -10.632195899167314%
Tax burden factor: 0.6791286622767878
ROE archetype: Standard Business
DuPont ROE decomposition for MFML.NS (quarterly period ending 2025-06-30)
Net margin: 7.715303510373593%
EBIT margin: 5.597622755670121%
Interest burden factor: 1.0380023451657605
Tax burden factor: 1.3278562259306805
ROE archetype: Standard Business
DuPont ROE decomposition for MFML.NS (quarterly period ending 2025-09-30)
ROE: -3.49844338900269%
Net margin: -10.76331026021294%
Asset turnover: 0.1591671833980254
Equity multiplier (leverage): 2.0420927347532807
EBIT margin: 6.022305773128722%
Interest burden factor: -1.2758204253084797
ROE archetype: Low Return
DuPont ROE decomposition for MFML.NS (quarterly period ending 2025-12-31)
Net margin: -2.3993326905511014%
EBIT margin: 6.4682076524916265%
Interest burden factor: -0.48690791409238016
ROE archetype: Standard Business
DuPont ROE decomposition for MFML.NS (quarterly period ending 2026-03-31)
ROE: 1.5871391062682019%
Net margin: 4.0345663849452515%
Asset turnover: 0.1923871933438629
Equity multiplier (leverage): 2.044758244064223
EBIT margin: 1.9052625005204216%
Interest burden factor: 1.9321223709369024
Tax burden factor: 1.0959920831271648
ROE archetype: Low Return
DuPont ROE decomposition for MGG.V (quarterly period ending 2025-01-31)
ROE: -7.865062575535546%
Asset turnover: 0
Equity multiplier (leverage): 1.032150396969678
ROE archetype: Low Return
DuPont ROE decomposition for MGG.V (quarterly period ending 2025-04-30)
ROE: -26.98360712368219%
Asset turnover: 0
Equity multiplier (leverage): 1.0536902307637757
ROE archetype: Low Return
DuPont ROE decomposition for MGG.V (quarterly period ending 2025-07-31)
ROE: -17.25445900350648%
Asset turnover: 0
Equity multiplier (leverage): 1.0987902991531575
ROE archetype: Low Return
DuPont ROE decomposition for MGG.V (quarterly period ending 2025-10-31)
ROE: -34.50887851298947%
Asset turnover: 0
Equity multiplier (leverage): 1.1198205461036712
ROE archetype: Low Return
DuPont ROE decomposition for MGG.V (quarterly period ending 2026-01-31)
ROE: -16.767945786508403%
Asset turnover: 0
Equity multiplier (leverage): 1.05802311368086
ROE archetype: Low Return
DuPont ROE decomposition for MGTX (annual period ending 2022-12-31)
ROE: -110.08765224481476%
Net margin: -814.1645728643216%
Asset turnover: 0.05002560984423558
Equity multiplier (leverage): 2.702925138867655
EBIT margin: -730.8731155778895%
ROE archetype: Low Return
DuPont ROE decomposition for MGTX (annual period ending 2023-12-31)
ROE: -65.66789754410645%
Net margin: -599.4649354355425%
Asset turnover: 0.043464846251284925
Equity multiplier (leverage): 2.520293847566575
EBIT margin: -977.8197902546907%
ROE archetype: Low Return
DuPont ROE decomposition for MGTX (annual period ending 2024-12-31)
ROE: -143.483621677249%
Net margin: -444.09687791099486%
Asset turnover: 0.11158182382081995
Equity multiplier (leverage): 2.8955505718335566
EBIT margin: -493.4403077015535%
ROE archetype: Low Return
DuPont ROE decomposition for MGTX (annual period ending 2025-12-31)
ROE: -368.18841280588066%
Net margin: -4199.385349953247%
Asset turnover: 0.01057786814370815
Equity multiplier (leverage): 8.288696521262533
EBIT margin: -1705.2557020672643%
ROE archetype: Low Return
DuPont ROE decomposition for MHLXMIRU.NS (annual period ending 2022-03-31)
ROE: 9.26405891901305%
Net margin: 3.75310394122003%
Asset turnover: 1.0107183027263411
Equity multiplier (leverage): 2.442196395862754
EBIT margin: 5.024239321978736%
Interest burden factor: 1.0042638241172552
Tax burden factor: 0.7438278849981119
ROE archetype: Standard Business
DuPont ROE decomposition for MHLXMIRU.NS (annual period ending 2023-03-31)
ROE: 17.165381438566538%
Net margin: 15.77993883969333%
Asset turnover: 0.49258206671221655
Equity multiplier (leverage): 2.208358343011673
EBIT margin: 19.36288931723648%
Interest burden factor: 0.9264232571368692
Tax burden factor: 0.8796819959279967
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MHLXMIRU.NS (annual period ending 2024-03-31)
ROE: 23.175206356858645%
Net margin: 14.502534608545254%
Asset turnover: 0.9786004486416474
Equity multiplier (leverage): 1.6329552705314263
EBIT margin: 19.703837858653355%
Interest burden factor: 0.9872732123799358
Tax burden factor: 0.7455138772531957
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MHLXMIRU.NS (annual period ending 2025-03-31)
ROE: 27.284584315203393%
Net margin: 18.2116401656926%
Asset turnover: 1.0077481862008912
Equity multiplier (leverage): 1.4866757441115765
EBIT margin: 22.035140204771047%
Interest burden factor: 1.0802096624021518
Tax burden factor: 0.7651123019040019
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MHLXMIRU.NS (annual period ending 2026-03-31)
ROE: 26.16660089116919%
Net margin: 19.4528715225093%
Asset turnover: 0.9997051045222876
Equity multiplier (leverage): 1.345524723656279
EBIT margin: 23.111230583610258%
Interest burden factor: 1.1366887570763375
Tax burden factor: 0.7404898047987816
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MI (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0707626032498516
ROE archetype: Standard Business
DuPont ROE decomposition for MI (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.1954115680040676
ROE archetype: Standard Business
DuPont ROE decomposition for MI (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.17759910817514
ROE archetype: Standard Business
DuPont ROE decomposition for MICEL.NS (annual period ending 2023-03-31)
ROE: 0.24218391339929074%
Net margin: 2.904969972666148%
Asset turnover: 0.06838340330258506
Equity multiplier (leverage): 1.219138184552126
EBIT margin: -17.05273238762196%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for MICEL.NS (annual period ending 2024-03-31)
ROE: 67.5737386103631%
Net margin: 123.59405042191479%
Asset turnover: 0.4649879061410902
Equity multiplier (leverage): 1.175814265363272
EBIT margin: 25.02048615136168%
Interest burden factor: 1.4165528369559137
Tax burden factor: 3.487137266401254
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for MICEL.NS (annual period ending 2025-03-31)
ROE: 5.655057558430647%
Net margin: 10.37454215063363%
Asset turnover: 0.41347122306112105
Equity multiplier (leverage): 1.3183259516249433
EBIT margin: 17.347148749996045%
Interest burden factor: 0.7949424532204297
Tax burden factor: 0.7523243979522342
ROE archetype: Standard Business
DuPont ROE decomposition for MICEL.NS (annual period ending 2026-03-31)
ROE: -5.465441511648761%
Net margin: -6.630996507515613%
Asset turnover: 0.5439466238215723
Equity multiplier (leverage): 1.515270493427763
EBIT margin: 11.319501961438858%
Interest burden factor: 0.7734196408285149
Tax burden factor: -0.7574191537068791
ROE archetype: Low Return
DuPont ROE decomposition for MIR.V (annual period ending 2022-07-31)
Net margin: -192.3667746004472%
Asset turnover: 0.2486248466865627
EBIT margin: -133.33725437888012%
ROE archetype: Standard Business
DuPont ROE decomposition for MIR.V (annual period ending 2023-07-31)
Net margin: -618.6077696524395%
Asset turnover: 0.11336150728712716
EBIT margin: -411.1021457520768%
ROE archetype: Standard Business
DuPont ROE decomposition for MIR.V (annual period ending 2024-07-31)
Net margin: -806.2479397335712%
Asset turnover: 0.08369574558133008
EBIT margin: -588.9715149987396%
ROE archetype: Standard Business
DuPont ROE decomposition for MIR.V (annual period ending 2025-07-31)
Net margin: -1881.1799142651626%
Asset turnover: 0.04932769685501041
EBIT margin: -1433.9808489495197%
ROE archetype: Standard Business
DuPont ROE decomposition for MKC.V (quarterly period ending 2025-02-28)
ROE: 2.998330183312843%
Net margin: 10.177514792899409%
Asset turnover: 0.12445929394254175
Equity multiplier (leverage): 2.367066077031763
EBIT margin: 14.026782933665524%
Interest burden factor: 0.8281527531083481
Tax burden factor: 0.8761394101876676
ROE archetype: Low Return
DuPont ROE decomposition for MKC.V (quarterly period ending 2025-05-31)
ROE: 3.176866634777664%
Net margin: 10.605604097619766%
Asset turnover: 0.12721251657710558
Equity multiplier (leverage): 2.3546899396214838
EBIT margin: 15.583006929798133%
Interest burden factor: 0.7911832946635731
Tax burden factor: 0.8602150537634409
ROE archetype: Low Return
DuPont ROE decomposition for MKC.V (quarterly period ending 2025-08-31)
ROE: 3.9512878920623793%
Net margin: 13.073221636036871%
Asset turnover: 0.1304893824657493
Equity multiplier (leverage): 2.3162256877518836
EBIT margin: 16.963302220418576%
Interest burden factor: 0.8472317156527683
Tax burden factor: 0.9096409842678499
ROE archetype: Low Return
DuPont ROE decomposition for MKC.V (quarterly period ending 2025-11-30)
ROE: 3.9232320783953876%
Net margin: 12.246000864677907%
Asset turnover: 0.13993057918736815
Equity multiplier (leverage): 2.289481201901019
EBIT margin: 17.05036748811068%
Interest burden factor: 0.8684627575277337
Tax burden factor: 0.827007299270073
ROE archetype: Low Return
DuPont ROE decomposition for MKC.V (quarterly period ending 2026-02-28)
ROE: 15.345011332762942%
Net margin: 54.55467207428358%
Asset turnover: 0.12684326845299138
Equity multiplier (leverage): 2.217521502229027
EBIT margin: 13.479908212818186%
Interest burden factor: 0.7323832145684878
Tax burden factor: 5.525945945945946
ROE archetype: Balanced Compounder
DuPont ROE decomposition for MKC.V (quarterly period ending 2026-05-31)
ROE: 2.1177310402263143%
Net margin: 8.272229680884022%
Asset turnover: 0.1180011820835136
Equity multiplier (leverage): 2.169511018282285
EBIT margin: 17.370649592068574%
Interest burden factor: 0.654577883472057
Tax burden factor: 0.7275204359673024
ROE archetype: Low Return
DuPont ROE decomposition for MKO.V (quarterly period ending 2025-03-31)
ROE: 10.868913339330613%
Net margin: 29.64640744935196%
Asset turnover: 0.24577843755798848
Equity multiplier (leverage): 1.4916614767144143
EBIT margin: 42.45627280734869%
Interest burden factor: 0.9242738589211618
Tax burden factor: 0.7554914221580888
ROE archetype: Standard Business
DuPont ROE decomposition for MKO.V (quarterly period ending 2025-06-30)
ROE: 9.824085258301638%
Net margin: 22.77670153687201%
Asset turnover: 0.28866552771534393
Equity multiplier (leverage): 1.494191867016695
EBIT margin: 36.12036678290068%
Interest burden factor: 1.1296481693363845
Tax burden factor: 0.5582072545420017
ROE archetype: Standard Business
DuPont ROE decomposition for MKO.V (quarterly period ending 2025-09-30)
ROE: 1.2221226941759387%
Net margin: 4.337262012692657%
Asset turnover: 0.1851634647686657
Equity multiplier (leverage): 1.521751896159699
EBIT margin: 13.323662737987307%
Interest burden factor: 1.1532389765922701
Tax burden factor: 0.2822751947132405
ROE archetype: Low Return
DuPont ROE decomposition for MKO.V (quarterly period ending 2025-12-31)
ROE: 11.571579304641668%
Net margin: 28.380362741596223%
Asset turnover: 0.28178307505640476
Equity multiplier (leverage): 1.446970875677313
EBIT margin: 45.84672778505377%
Interest burden factor: 0.9603531855955678
Tax burden factor: 0.6445826572922301
ROE archetype: Standard Business
DuPont ROE decomposition for MKO.V (quarterly period ending 2026-03-31)
ROE: 14.14316450336241%
Net margin: 33.747357679131134%
Asset turnover: 0.2824007502306907
Equity multiplier (leverage): 1.4840241628869884
EBIT margin: 49.967198775420954%
Interest burden factor: 1.0275711159737417
Tax burden factor: 0.6572685973878478
ROE archetype: Standard Business
DuPont ROE decomposition for MKS.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.864038271197624
ROE archetype: Standard Business
DuPont ROE decomposition for MKS.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 2.9836147691852135
ROE archetype: Standard Business
DuPont ROE decomposition for MKS.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 3.1275452499062877
ROE archetype: Standard Business
DuPont ROE decomposition for MKT.V (quarterly period ending 2024-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MKT.V (quarterly period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MKT.V (quarterly period ending 2025-03-31)
Asset turnover: 0
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for MKT.V (quarterly period ending 2025-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for MKT.V (quarterly period ending 2025-12-31)
ROE: -85.77555401738374%
Asset turnover: 0
Equity multiplier (leverage): 2.1971866339637502
ROE archetype: Low Return
DuPont ROE decomposition for MKT.V (quarterly period ending 2026-03-31)
ROE: -64.73058753401027%
Asset turnover: 0
Equity multiplier (leverage): 1.3911210696346679
ROE archetype: Low Return
DuPont ROE decomposition for MLAIG.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.3055429248134955
ROE archetype: Standard Business
DuPont ROE decomposition for MLAIG.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.28684773641098
ROE archetype: Standard Business
DuPont ROE decomposition for MLAIG.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.3772520434720366
ROE archetype: Standard Business
DuPont ROE decomposition for MLB1.DE (annual period ending 2022-12-31)
ROE: 26.382047071702246%
Net margin: 4.471243042671614%
Asset turnover: 0.7847990681421084
Equity multiplier (leverage): 7.518336070060209
EBIT margin: 9.916512059369202%
Interest burden factor: 0.7296538821328344
Tax burden factor: 0.6179487179487179
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MLB1.DE (annual period ending 2023-12-31)
ROE: 40.53572519643665%
Net margin: 6.533395114847422%
Asset turnover: 0.9703935630099758
Equity multiplier (leverage): 6.3936832433256
EBIT margin: 14.609121599258623%
Interest burden factor: 0.7036701404621659
Tax burden factor: 0.6355441081777206
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MLB1.DE (annual period ending 2024-12-31)
ROE: 49.202098124239754%
Net margin: 9.197670501034798%
Asset turnover: 0.9277088990761841
Equity multiplier (leverage): 5.766257770968479
EBIT margin: 12.663040862492178%
Interest burden factor: 0.9243633599391866
Tax burden factor: 0.7857730263157895
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MLB1.DE (annual period ending 2025-12-31)
ROE: 37.55405608746374%
Net margin: 6.911708718374693%
Asset turnover: 0.8865876434904865
Equity multiplier (leverage): 6.1284373268457175
EBIT margin: 11.07880801578237%
Interest burden factor: 0.8878475476413621
Tax burden factor: 0.7026741731175229
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MLCHE.PA (annual period ending 2022-04-30)
ROE: 28.00136702260019%
Net margin: 4.57801016346181%
Asset turnover: 1.765712474556858
Equity multiplier (leverage): 3.464036793722065
EBIT margin: 7.044887162251855%
Interest burden factor: 1.0382521402199902
Tax burden factor: 0.6258926852981366
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MLCHE.PA (annual period ending 2023-04-30)
ROE: 30.55444358680168%
Net margin: 4.585033288456428%
Asset turnover: 2.03178237183511
Equity multiplier (leverage): 3.2798554079419717
EBIT margin: 6.994995795535476%
Interest burden factor: 1.0431454972727376
Tax burden factor: 0.6283623388641131
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MLCHE.PA (annual period ending 2024-04-30)
ROE: 26.973816078442702%
Net margin: 4.458725297657588%
Asset turnover: 1.964256230138854
Equity multiplier (leverage): 3.079878161601294
EBIT margin: 6.428568022629877%
Interest burden factor: 1.0686496204430576
Tax burden factor: 0.649024567965407
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MLCHE.PA (annual period ending 2025-04-30)
ROE: 24.288722487612013%
Net margin: 4.609489263727404%
Asset turnover: 1.8112374921854235
Equity multiplier (leverage): 2.909219337714049
EBIT margin: 6.689333304710324%
Interest burden factor: 1.070761360957151
Tax burden factor: 0.6435425706227519
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for MLCMI.PA (annual period ending 2021-12-31)
ROE: 3.2455361122217954%
Net margin: 3.7305706519760347%
Asset turnover: 0.5741390257578907
Equity multiplier (leverage): 1.5152842473341468
EBIT margin: 3.2772418549422353%
Interest burden factor: 1.7522132253213947
Tax burden factor: 0.6496505681803698
ROE archetype: Low Return
DuPont ROE decomposition for MLCMI.PA (annual period ending 2022-12-31)
ROE: 13.358211727182779%
Net margin: 15.32077427065574%
Asset turnover: 0.635523950112577
Equity multiplier (leverage): 1.371941795807704
EBIT margin: 10.415563966017434%
Interest burden factor: 1.6757702141918387
Tax burden factor: 0.8777755035936576
ROE archetype: Standard Business
DuPont ROE decomposition for MLCMI.PA (annual period ending 2023-12-31)
ROE: 2.9810939617094867%
Net margin: 3.0355848468113233%
Asset turnover: 0.7460150804618031
Equity multiplier (leverage): 1.3163933567879975
EBIT margin: 0.2565102236266237%
Interest burden factor: 15.847613571017824
Tax burden factor: 0.7467475804756181
ROE archetype: Low Return